Global Nuclear Medicine Radioisotope Production Systems Market Growth 2026-2032
The global Nuclear Medicine Radioisotope Production Systems market size is predicted to grow from US$ 995 million in 2025 to US$ 1957 million in 2032; it is expected to grow at a CAGR of 10.3% from 2026 to 2032.
Nuclear Medicine Radioisotope Production Systems are integrated system level equipment used to produce, separate, process and prepare medical radionuclides for nuclear medicine diagnosis, therapy and radiopharmaceutical research. Their core function is to convert stable target materials, parent nuclides or precursor materials into clinically usable medical radioisotopes through particle acceleration, target irradiation, reactor neutron irradiation, generator elution, radiochemical separation, shielded transfer and automated dispensing. These systems mainly cover medical cyclotron systems, solid target systems, liquid target systems, gas target systems, radionuclide transfer systems, hot cells, shielded isolators, automated dispensing units, radiochemistry synthesis modules, generator and separation modules, quality control units, radiation monitoring devices, safety interlock systems and clean production infrastructure. Key specifications include particle energy, beam current, target power handling capacity, isotope yield, radiochemical purity, automation level, shielding thickness, cleanroom grade, system availability, remote maintenance capability and GMP compatibility. The main applications include PET diagnostic isotope production, SPECT diagnostic isotope production, therapeutic isotope production, parent isotope preparation, on site production in hospital nuclear medicine centers, regional supply by commercial radiopharmacies, national isotope center construction and translational research for radiopharmaceuticals. The product is positioned as a high reliability and high compliance production system rather than a single laboratory instrument, because it combines nuclear engineering, radiation protection, radiochemistry, pharmaceutical manufacturing and digital quality management. In 2025, the global average price of Nuclear Medicine Radioisotope Production Systems was approximately USD 2.5 million to USD 8.0 million per unit, the number of new and upgraded equivalent system units was about 150 to 220 units, and the global average gross margin was about 35% to 50%.
Nuclear Medicine Radioisotope Production Systems are positioned in the midstream equipment layer of the nuclear medicine value chain. The upstream side includes accelerator components, target materials, shielding materials, vacuum systems, RF systems, magnets, power supplies, hot cell materials, automation control, cleanroom engineering and quality control instruments. The midstream layer consists of radionuclide production systems, target systems, hot cells, generator platforms, separation modules and integrated production lines. The downstream side includes hospital nuclear medicine departments, commercial radiopharmacies, national isotope centers, radiopharmaceutical research organizations and therapeutic radiopharmaceutical production sites. The strategic value of this industry is not limited to the equipment itself. Its real value lies in the ability to create stable, safe and compliant isotope production capacity, while supporting the transition from diagnostic isotope supply to therapeutic isotope production and theranostic isotope platforms.
The global competitive landscape is shaped by both high technical specialization and regional supply chain restructuring. Europe, North America and Japan have accumulated strong capabilities in medical cyclotrons, high performance target systems, hot cells, radiochemistry automation and in reactor isotope production engineering. These regions still dominate the high end system and critical subsystem segments. China, parts of Asia and the Middle East are showing faster demand growth, supported by nuclear medicine center expansion, regional radiopharmacy construction, import substitution and broader healthcare infrastructure investment. As isotope supply security becomes a policy priority for healthcare systems and nuclear technology programs, more countries are investing in domestic production capacity. This trend is increasing the importance of localized, compact, modular and serviceable production systems.
The application structure is shifting from conventional PET diagnostic isotope production toward multi isotope production platforms. Historically, demand was mainly driven by routine PET and SPECT isotopes, with system configurations centered on low energy medical cyclotrons, hot cells and dispensing equipment. Current growth is increasingly linked to therapeutic isotopes, parent isotopes, solid target processing, generator separation and complete GMP production lines. Theranostic drugs, targeted radioligand therapy and the need for local supply of short lived isotopes are encouraging customers to move from single equipment purchases to system level investment. In the future product mix, high automation target systems, remote operated hot cells, digital batch records, automated synthesis and dispensing, and high activity handling capability will become more important.
Policy environment and capital expenditure cycles have a strong influence on this market. Medical isotope supply is connected with public health, nuclear safety, drug regulation, radiation protection and strategic supply security, so government support, nuclear facility licensing, hospital construction plans and radiopharmaceutical approval schedules all affect equipment procurement. Recent global isotope supply disruptions, aging reactor infrastructure, rising interest in therapeutic radiopharmaceuticals and the expansion of nuclear medicine services are moving the industry from occasional equipment purchases toward long term capacity building. The outlook is positive, but equipment market growth will not fully mirror the growth rate of radiopharmaceutical sales because system delivery cycles are long, installation and validation are complex, regulatory review is strict and customer capital spending is staged. Overall, the industry is expected to maintain steady growth, with high end system capability and localized supply support becoming the key competitive priorities.
LP Information, Inc. (LPI) ' newest research report, the “Nuclear Medicine Radioisotope Production Systems Industry Forecast” looks at past sales and reviews total world Nuclear Medicine Radioisotope Production Systems sales in 2025, providing a comprehensive analysis by region and market sector of projected Nuclear Medicine Radioisotope Production Systems sales for 2026 through 2032. With Nuclear Medicine Radioisotope Production Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nuclear Medicine Radioisotope Production Systems industry.
This Insight Report provides a comprehensive analysis of the global Nuclear Medicine Radioisotope Production Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nuclear Medicine Radioisotope Production Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nuclear Medicine Radioisotope Production Systems market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclear Medicine Radioisotope Production Systems and breaks down the forecast by Production Route, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclear Medicine Radioisotope Production Systems.
This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine Radioisotope Production Systems market by product type, application, key manufacturers and key regions and countries.
Nuclear Medicine Radioisotope Production Systems are integrated system level equipment used to produce, separate, process and prepare medical radionuclides for nuclear medicine diagnosis, therapy and radiopharmaceutical research. Their core function is to convert stable target materials, parent nuclides or precursor materials into clinically usable medical radioisotopes through particle acceleration, target irradiation, reactor neutron irradiation, generator elution, radiochemical separation, shielded transfer and automated dispensing. These systems mainly cover medical cyclotron systems, solid target systems, liquid target systems, gas target systems, radionuclide transfer systems, hot cells, shielded isolators, automated dispensing units, radiochemistry synthesis modules, generator and separation modules, quality control units, radiation monitoring devices, safety interlock systems and clean production infrastructure. Key specifications include particle energy, beam current, target power handling capacity, isotope yield, radiochemical purity, automation level, shielding thickness, cleanroom grade, system availability, remote maintenance capability and GMP compatibility. The main applications include PET diagnostic isotope production, SPECT diagnostic isotope production, therapeutic isotope production, parent isotope preparation, on site production in hospital nuclear medicine centers, regional supply by commercial radiopharmacies, national isotope center construction and translational research for radiopharmaceuticals. The product is positioned as a high reliability and high compliance production system rather than a single laboratory instrument, because it combines nuclear engineering, radiation protection, radiochemistry, pharmaceutical manufacturing and digital quality management. In 2025, the global average price of Nuclear Medicine Radioisotope Production Systems was approximately USD 2.5 million to USD 8.0 million per unit, the number of new and upgraded equivalent system units was about 150 to 220 units, and the global average gross margin was about 35% to 50%.
Nuclear Medicine Radioisotope Production Systems are positioned in the midstream equipment layer of the nuclear medicine value chain. The upstream side includes accelerator components, target materials, shielding materials, vacuum systems, RF systems, magnets, power supplies, hot cell materials, automation control, cleanroom engineering and quality control instruments. The midstream layer consists of radionuclide production systems, target systems, hot cells, generator platforms, separation modules and integrated production lines. The downstream side includes hospital nuclear medicine departments, commercial radiopharmacies, national isotope centers, radiopharmaceutical research organizations and therapeutic radiopharmaceutical production sites. The strategic value of this industry is not limited to the equipment itself. Its real value lies in the ability to create stable, safe and compliant isotope production capacity, while supporting the transition from diagnostic isotope supply to therapeutic isotope production and theranostic isotope platforms.
The global competitive landscape is shaped by both high technical specialization and regional supply chain restructuring. Europe, North America and Japan have accumulated strong capabilities in medical cyclotrons, high performance target systems, hot cells, radiochemistry automation and in reactor isotope production engineering. These regions still dominate the high end system and critical subsystem segments. China, parts of Asia and the Middle East are showing faster demand growth, supported by nuclear medicine center expansion, regional radiopharmacy construction, import substitution and broader healthcare infrastructure investment. As isotope supply security becomes a policy priority for healthcare systems and nuclear technology programs, more countries are investing in domestic production capacity. This trend is increasing the importance of localized, compact, modular and serviceable production systems.
The application structure is shifting from conventional PET diagnostic isotope production toward multi isotope production platforms. Historically, demand was mainly driven by routine PET and SPECT isotopes, with system configurations centered on low energy medical cyclotrons, hot cells and dispensing equipment. Current growth is increasingly linked to therapeutic isotopes, parent isotopes, solid target processing, generator separation and complete GMP production lines. Theranostic drugs, targeted radioligand therapy and the need for local supply of short lived isotopes are encouraging customers to move from single equipment purchases to system level investment. In the future product mix, high automation target systems, remote operated hot cells, digital batch records, automated synthesis and dispensing, and high activity handling capability will become more important.
Policy environment and capital expenditure cycles have a strong influence on this market. Medical isotope supply is connected with public health, nuclear safety, drug regulation, radiation protection and strategic supply security, so government support, nuclear facility licensing, hospital construction plans and radiopharmaceutical approval schedules all affect equipment procurement. Recent global isotope supply disruptions, aging reactor infrastructure, rising interest in therapeutic radiopharmaceuticals and the expansion of nuclear medicine services are moving the industry from occasional equipment purchases toward long term capacity building. The outlook is positive, but equipment market growth will not fully mirror the growth rate of radiopharmaceutical sales because system delivery cycles are long, installation and validation are complex, regulatory review is strict and customer capital spending is staged. Overall, the industry is expected to maintain steady growth, with high end system capability and localized supply support becoming the key competitive priorities.
LP Information, Inc. (LPI) ' newest research report, the “Nuclear Medicine Radioisotope Production Systems Industry Forecast” looks at past sales and reviews total world Nuclear Medicine Radioisotope Production Systems sales in 2025, providing a comprehensive analysis by region and market sector of projected Nuclear Medicine Radioisotope Production Systems sales for 2026 through 2032. With Nuclear Medicine Radioisotope Production Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nuclear Medicine Radioisotope Production Systems industry.
This Insight Report provides a comprehensive analysis of the global Nuclear Medicine Radioisotope Production Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nuclear Medicine Radioisotope Production Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nuclear Medicine Radioisotope Production Systems market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclear Medicine Radioisotope Production Systems and breaks down the forecast by Production Route, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclear Medicine Radioisotope Production Systems.
This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine Radioisotope Production Systems market by product type, application, key manufacturers and key regions and countries.
Segmentation by Production Route:
- Cyclotron based Production Systems
- Reactor Irradiation Production Systems
- Generator and Separation Production Systems
- Electron Accelerator and Neutron Source Production Systems
- Others
Segmentation by Energy Level:
- Compact Low Energy Systems (≤20 MeV)
- Medium Energy Multi Isotope Systems (20 to 35 MeV)
- High Energy Isotope Production Systems (>35 MeV)
- Others
Segmentation by Application:
- Hospital Nuclear Medicine Centers
- Commercial Radiopharmacies
- National Isotope Production Centers
- Research Institutes and Universities
- Nuclear Reactor Facilities
- Radiopharmaceutical CDMO Sites
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Ion Beam Applications SA
- GE HealthCare Technologies Inc.
- Sumitomo Heavy Industries, Ltd.
- Advanced Cyclotron Systems Inc.
- Best Theratronics Ltd.
- PMB SAS
- Sichuan Longevous Beamtech Co., Ltd.
- China Institute of Atomic Energy
- ARTMS Inc.
- Comecer S.p.A.
- Tema Sinergie S.p.A.
- Von Gahlen International B.V.
- Trasis S.A.
- Eckert & Ziegler Medical GmbH
- Kinectrics Inc.
- Framatome
- NorthStar Medical Radioisotopes, LLC
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Nuclear Medicine Radioisotope Production Systems market?
- What factors are driving Nuclear Medicine Radioisotope Production Systems market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Nuclear Medicine Radioisotope Production Systems market opportunities vary by end market size?
- How does Nuclear Medicine Radioisotope Production Systems break out by Production Route, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nuclear Medicine Radioisotope Production Systems Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Nuclear Medicine Radioisotope Production Systems by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Nuclear Medicine Radioisotope Production Systems by Country/Region, 2021, 2025 & 2032
2.2 Nuclear Medicine Radioisotope Production Systems Segment by Production Route
2.2.1 Cyclotron based Production Systems
2.2.2 Reactor Irradiation Production Systems
2.2.3 Generator and Separation Production Systems
2.2.4 Electron Accelerator and Neutron Source Production Systems
2.2.5 Others
2.2.6 Nuclear Medicine Radioisotope Production Systems Sales by Production Route
2.2.6.1 Global Nuclear Medicine Radioisotope Production Systems Sales Market Share by Production Route (2021-2026)
2.2.6.2 Global Nuclear Medicine Radioisotope Production Systems Revenue and Market Share by Production Route (2021-2026)
2.2.6.3 Global Nuclear Medicine Radioisotope Production Systems Sale Price by Production Route (2021-2026)
2.3 Nuclear Medicine Radioisotope Production Systems Segment by Energy Level
2.3.1 Compact Low Energy Systems (≤20 MeV)
2.3.2 Medium Energy Multi Isotope Systems (20 to 35 MeV)
2.3.3 High Energy Isotope Production Systems (>35 MeV)
2.3.4 Others
2.3.5 Nuclear Medicine Radioisotope Production Systems Sales by Energy Level
2.3.5.1 Global Nuclear Medicine Radioisotope Production Systems Sales Market Share by Energy Level (2021-2026)
2.3.5.2 Global Nuclear Medicine Radioisotope Production Systems Revenue and Market Share by Energy Level (2021-2026)
2.3.5.3 Global Nuclear Medicine Radioisotope Production Systems Sale Price by Energy Level (2021-2026)
2.4 Nuclear Medicine Radioisotope Production Systems Segment by Application
2.4.1 Hospital Nuclear Medicine Centers
2.4.2 Commercial Radiopharmacies
2.4.3 National Isotope Production Centers
2.4.4 Research Institutes and Universities
2.4.5 Nuclear Reactor Facilities
2.4.6 Radiopharmaceutical CDMO Sites
2.4.7 Others
2.4.8 Nuclear Medicine Radioisotope Production Systems Sales by Application
2.4.8.1 Global Nuclear Medicine Radioisotope Production Systems Sale Market Share by Application (2021-2026)
2.4.8.2 Global Nuclear Medicine Radioisotope Production Systems Revenue and Market Share by Application (2021-2026)
2.4.8.3 Global Nuclear Medicine Radioisotope Production Systems Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Nuclear Medicine Radioisotope Production Systems Breakdown Data by Company
3.1.1 Global Nuclear Medicine Radioisotope Production Systems Annual Sales by Company (2021-2026)
3.1.2 Global Nuclear Medicine Radioisotope Production Systems Sales Market Share by Company (2021-2026)
3.2 Global Nuclear Medicine Radioisotope Production Systems Annual Revenue by Company (2021-2026)
3.2.1 Global Nuclear Medicine Radioisotope Production Systems Revenue by Company (2021-2026)
3.2.2 Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Company (2021-2026)
3.3 Global Nuclear Medicine Radioisotope Production Systems Sale Price by Company
3.4 Key Manufacturers Nuclear Medicine Radioisotope Production Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nuclear Medicine Radioisotope Production Systems Product Location Distribution
3.4.2 Players Nuclear Medicine Radioisotope Production Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NUCLEAR MEDICINE RADIOISOTOPE PRODUCTION SYSTEMS BY GEOGRAPHIC REGION
4.1 World Historic Nuclear Medicine Radioisotope Production Systems Market Size by Geographic Region (2021-2026)
4.1.1 Global Nuclear Medicine Radioisotope Production Systems Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Nuclear Medicine Radioisotope Production Systems Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Nuclear Medicine Radioisotope Production Systems Market Size by Country/Region (2021-2026)
4.2.1 Global Nuclear Medicine Radioisotope Production Systems Annual Sales by Country/Region (2021-2026)
4.2.2 Global Nuclear Medicine Radioisotope Production Systems Annual Revenue by Country/Region (2021-2026)
4.3 Americas Nuclear Medicine Radioisotope Production Systems Sales Growth
4.4 APAC Nuclear Medicine Radioisotope Production Systems Sales Growth
4.5 Europe Nuclear Medicine Radioisotope Production Systems Sales Growth
4.6 Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Growth
5 AMERICAS
5.1 Americas Nuclear Medicine Radioisotope Production Systems Sales by Country
5.1.1 Americas Nuclear Medicine Radioisotope Production Systems Sales by Country (2021-2026)
5.1.2 Americas Nuclear Medicine Radioisotope Production Systems Revenue by Country (2021-2026)
5.2 Americas Nuclear Medicine Radioisotope Production Systems Sales by Production Route (2021-2026)
5.3 Americas Nuclear Medicine Radioisotope Production Systems Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Medicine Radioisotope Production Systems Sales by Region
6.1.1 APAC Nuclear Medicine Radioisotope Production Systems Sales by Region (2021-2026)
6.1.2 APAC Nuclear Medicine Radioisotope Production Systems Revenue by Region (2021-2026)
6.2 APAC Nuclear Medicine Radioisotope Production Systems Sales by Production Route (2021-2026)
6.3 APAC Nuclear Medicine Radioisotope Production Systems Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nuclear Medicine Radioisotope Production Systems by Country
7.1.1 Europe Nuclear Medicine Radioisotope Production Systems Sales by Country (2021-2026)
7.1.2 Europe Nuclear Medicine Radioisotope Production Systems Revenue by Country (2021-2026)
7.2 Europe Nuclear Medicine Radioisotope Production Systems Sales by Production Route (2021-2026)
7.3 Europe Nuclear Medicine Radioisotope Production Systems Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nuclear Medicine Radioisotope Production Systems by Country
8.1.1 Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales by Country (2021-2026)
8.1.2 Middle East & Africa Nuclear Medicine Radioisotope Production Systems Revenue by Country (2021-2026)
8.2 Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales by Production Route (2021-2026)
8.3 Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nuclear Medicine Radioisotope Production Systems
10.3 Manufacturing Process Analysis of Nuclear Medicine Radioisotope Production Systems
10.4 Industry Chain Structure of Nuclear Medicine Radioisotope Production Systems
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nuclear Medicine Radioisotope Production Systems Distributors
11.3 Nuclear Medicine Radioisotope Production Systems Customer
12 WORLD FORECAST REVIEW FOR NUCLEAR MEDICINE RADIOISOTOPE PRODUCTION SYSTEMS BY GEOGRAPHIC REGION
12.1 Global Nuclear Medicine Radioisotope Production Systems Market Size Forecast by Region
12.1.1 Global Nuclear Medicine Radioisotope Production Systems Forecast by Region (2027-2032)
12.1.2 Global Nuclear Medicine Radioisotope Production Systems Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Nuclear Medicine Radioisotope Production Systems Forecast by Production Route (2027-2032)
12.7 Global Nuclear Medicine Radioisotope Production Systems Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Ion Beam Applications SA
13.1.1 Ion Beam Applications SA Company Information
13.1.2 Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.1.3 Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Ion Beam Applications SA Main Business Overview
13.1.5 Ion Beam Applications SA Latest Developments
13.2 GE HealthCare Technologies Inc.
13.2.1 GE HealthCare Technologies Inc. Company Information
13.2.2 GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.2.3 GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GE HealthCare Technologies Inc. Main Business Overview
13.2.5 GE HealthCare Technologies Inc. Latest Developments
13.3 Sumitomo Heavy Industries, Ltd.
13.3.1 Sumitomo Heavy Industries, Ltd. Company Information
13.3.2 Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.3.3 Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sumitomo Heavy Industries, Ltd. Main Business Overview
13.3.5 Sumitomo Heavy Industries, Ltd. Latest Developments
13.4 Advanced Cyclotron Systems Inc.
13.4.1 Advanced Cyclotron Systems Inc. Company Information
13.4.2 Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.4.3 Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Advanced Cyclotron Systems Inc. Main Business Overview
13.4.5 Advanced Cyclotron Systems Inc. Latest Developments
13.5 Best Theratronics Ltd.
13.5.1 Best Theratronics Ltd. Company Information
13.5.2 Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.5.3 Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Best Theratronics Ltd. Main Business Overview
13.5.5 Best Theratronics Ltd. Latest Developments
13.6 PMB SAS
13.6.1 PMB SAS Company Information
13.6.2 PMB SAS Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.6.3 PMB SAS Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 PMB SAS Main Business Overview
13.6.5 PMB SAS Latest Developments
13.7 Sichuan Longevous Beamtech Co., Ltd.
13.7.1 Sichuan Longevous Beamtech Co., Ltd. Company Information
13.7.2 Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.7.3 Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Sichuan Longevous Beamtech Co., Ltd. Main Business Overview
13.7.5 Sichuan Longevous Beamtech Co., Ltd. Latest Developments
13.8 China Institute of Atomic Energy
13.8.1 China Institute of Atomic Energy Company Information
13.8.2 China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.8.3 China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 China Institute of Atomic Energy Main Business Overview
13.8.5 China Institute of Atomic Energy Latest Developments
13.9 ARTMS Inc.
13.9.1 ARTMS Inc. Company Information
13.9.2 ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.9.3 ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 ARTMS Inc. Main Business Overview
13.9.5 ARTMS Inc. Latest Developments
13.10 Comecer S.p.A.
13.10.1 Comecer S.p.A. Company Information
13.10.2 Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.10.3 Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Comecer S.p.A. Main Business Overview
13.10.5 Comecer S.p.A. Latest Developments
13.11 Tema Sinergie S.p.A.
13.11.1 Tema Sinergie S.p.A. Company Information
13.11.2 Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.11.3 Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Tema Sinergie S.p.A. Main Business Overview
13.11.5 Tema Sinergie S.p.A. Latest Developments
13.12 Von Gahlen International B.V.
13.12.1 Von Gahlen International B.V. Company Information
13.12.2 Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.12.3 Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Von Gahlen International B.V. Main Business Overview
13.12.5 Von Gahlen International B.V. Latest Developments
13.13 Trasis S.A.
13.13.1 Trasis S.A. Company Information
13.13.2 Trasis S.A. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.13.3 Trasis S.A. Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Trasis S.A. Main Business Overview
13.13.5 Trasis S.A. Latest Developments
13.14 Eckert & Ziegler Medical GmbH
13.14.1 Eckert & Ziegler Medical GmbH Company Information
13.14.2 Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.14.3 Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Eckert & Ziegler Medical GmbH Main Business Overview
13.14.5 Eckert & Ziegler Medical GmbH Latest Developments
13.15 Kinectrics Inc.
13.15.1 Kinectrics Inc. Company Information
13.15.2 Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.15.3 Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Kinectrics Inc. Main Business Overview
13.15.5 Kinectrics Inc. Latest Developments
13.16 Framatome
13.16.1 Framatome Company Information
13.16.2 Framatome Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.16.3 Framatome Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Framatome Main Business Overview
13.16.5 Framatome Latest Developments
13.17 NorthStar Medical Radioisotopes, LLC
13.17.1 NorthStar Medical Radioisotopes, LLC Company Information
13.17.2 NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.17.3 NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 NorthStar Medical Radioisotopes, LLC Main Business Overview
13.17.5 NorthStar Medical Radioisotopes, LLC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nuclear Medicine Radioisotope Production Systems Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Nuclear Medicine Radioisotope Production Systems by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Nuclear Medicine Radioisotope Production Systems by Country/Region, 2021, 2025 & 2032
2.2 Nuclear Medicine Radioisotope Production Systems Segment by Production Route
2.2.1 Cyclotron based Production Systems
2.2.2 Reactor Irradiation Production Systems
2.2.3 Generator and Separation Production Systems
2.2.4 Electron Accelerator and Neutron Source Production Systems
2.2.5 Others
2.2.6 Nuclear Medicine Radioisotope Production Systems Sales by Production Route
2.2.6.1 Global Nuclear Medicine Radioisotope Production Systems Sales Market Share by Production Route (2021-2026)
2.2.6.2 Global Nuclear Medicine Radioisotope Production Systems Revenue and Market Share by Production Route (2021-2026)
2.2.6.3 Global Nuclear Medicine Radioisotope Production Systems Sale Price by Production Route (2021-2026)
2.3 Nuclear Medicine Radioisotope Production Systems Segment by Energy Level
2.3.1 Compact Low Energy Systems (≤20 MeV)
2.3.2 Medium Energy Multi Isotope Systems (20 to 35 MeV)
2.3.3 High Energy Isotope Production Systems (>35 MeV)
2.3.4 Others
2.3.5 Nuclear Medicine Radioisotope Production Systems Sales by Energy Level
2.3.5.1 Global Nuclear Medicine Radioisotope Production Systems Sales Market Share by Energy Level (2021-2026)
2.3.5.2 Global Nuclear Medicine Radioisotope Production Systems Revenue and Market Share by Energy Level (2021-2026)
2.3.5.3 Global Nuclear Medicine Radioisotope Production Systems Sale Price by Energy Level (2021-2026)
2.4 Nuclear Medicine Radioisotope Production Systems Segment by Application
2.4.1 Hospital Nuclear Medicine Centers
2.4.2 Commercial Radiopharmacies
2.4.3 National Isotope Production Centers
2.4.4 Research Institutes and Universities
2.4.5 Nuclear Reactor Facilities
2.4.6 Radiopharmaceutical CDMO Sites
2.4.7 Others
2.4.8 Nuclear Medicine Radioisotope Production Systems Sales by Application
2.4.8.1 Global Nuclear Medicine Radioisotope Production Systems Sale Market Share by Application (2021-2026)
2.4.8.2 Global Nuclear Medicine Radioisotope Production Systems Revenue and Market Share by Application (2021-2026)
2.4.8.3 Global Nuclear Medicine Radioisotope Production Systems Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Nuclear Medicine Radioisotope Production Systems Breakdown Data by Company
3.1.1 Global Nuclear Medicine Radioisotope Production Systems Annual Sales by Company (2021-2026)
3.1.2 Global Nuclear Medicine Radioisotope Production Systems Sales Market Share by Company (2021-2026)
3.2 Global Nuclear Medicine Radioisotope Production Systems Annual Revenue by Company (2021-2026)
3.2.1 Global Nuclear Medicine Radioisotope Production Systems Revenue by Company (2021-2026)
3.2.2 Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Company (2021-2026)
3.3 Global Nuclear Medicine Radioisotope Production Systems Sale Price by Company
3.4 Key Manufacturers Nuclear Medicine Radioisotope Production Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nuclear Medicine Radioisotope Production Systems Product Location Distribution
3.4.2 Players Nuclear Medicine Radioisotope Production Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NUCLEAR MEDICINE RADIOISOTOPE PRODUCTION SYSTEMS BY GEOGRAPHIC REGION
4.1 World Historic Nuclear Medicine Radioisotope Production Systems Market Size by Geographic Region (2021-2026)
4.1.1 Global Nuclear Medicine Radioisotope Production Systems Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Nuclear Medicine Radioisotope Production Systems Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Nuclear Medicine Radioisotope Production Systems Market Size by Country/Region (2021-2026)
4.2.1 Global Nuclear Medicine Radioisotope Production Systems Annual Sales by Country/Region (2021-2026)
4.2.2 Global Nuclear Medicine Radioisotope Production Systems Annual Revenue by Country/Region (2021-2026)
4.3 Americas Nuclear Medicine Radioisotope Production Systems Sales Growth
4.4 APAC Nuclear Medicine Radioisotope Production Systems Sales Growth
4.5 Europe Nuclear Medicine Radioisotope Production Systems Sales Growth
4.6 Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Growth
5 AMERICAS
5.1 Americas Nuclear Medicine Radioisotope Production Systems Sales by Country
5.1.1 Americas Nuclear Medicine Radioisotope Production Systems Sales by Country (2021-2026)
5.1.2 Americas Nuclear Medicine Radioisotope Production Systems Revenue by Country (2021-2026)
5.2 Americas Nuclear Medicine Radioisotope Production Systems Sales by Production Route (2021-2026)
5.3 Americas Nuclear Medicine Radioisotope Production Systems Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Medicine Radioisotope Production Systems Sales by Region
6.1.1 APAC Nuclear Medicine Radioisotope Production Systems Sales by Region (2021-2026)
6.1.2 APAC Nuclear Medicine Radioisotope Production Systems Revenue by Region (2021-2026)
6.2 APAC Nuclear Medicine Radioisotope Production Systems Sales by Production Route (2021-2026)
6.3 APAC Nuclear Medicine Radioisotope Production Systems Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nuclear Medicine Radioisotope Production Systems by Country
7.1.1 Europe Nuclear Medicine Radioisotope Production Systems Sales by Country (2021-2026)
7.1.2 Europe Nuclear Medicine Radioisotope Production Systems Revenue by Country (2021-2026)
7.2 Europe Nuclear Medicine Radioisotope Production Systems Sales by Production Route (2021-2026)
7.3 Europe Nuclear Medicine Radioisotope Production Systems Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nuclear Medicine Radioisotope Production Systems by Country
8.1.1 Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales by Country (2021-2026)
8.1.2 Middle East & Africa Nuclear Medicine Radioisotope Production Systems Revenue by Country (2021-2026)
8.2 Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales by Production Route (2021-2026)
8.3 Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nuclear Medicine Radioisotope Production Systems
10.3 Manufacturing Process Analysis of Nuclear Medicine Radioisotope Production Systems
10.4 Industry Chain Structure of Nuclear Medicine Radioisotope Production Systems
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nuclear Medicine Radioisotope Production Systems Distributors
11.3 Nuclear Medicine Radioisotope Production Systems Customer
12 WORLD FORECAST REVIEW FOR NUCLEAR MEDICINE RADIOISOTOPE PRODUCTION SYSTEMS BY GEOGRAPHIC REGION
12.1 Global Nuclear Medicine Radioisotope Production Systems Market Size Forecast by Region
12.1.1 Global Nuclear Medicine Radioisotope Production Systems Forecast by Region (2027-2032)
12.1.2 Global Nuclear Medicine Radioisotope Production Systems Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Nuclear Medicine Radioisotope Production Systems Forecast by Production Route (2027-2032)
12.7 Global Nuclear Medicine Radioisotope Production Systems Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Ion Beam Applications SA
13.1.1 Ion Beam Applications SA Company Information
13.1.2 Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.1.3 Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Ion Beam Applications SA Main Business Overview
13.1.5 Ion Beam Applications SA Latest Developments
13.2 GE HealthCare Technologies Inc.
13.2.1 GE HealthCare Technologies Inc. Company Information
13.2.2 GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.2.3 GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GE HealthCare Technologies Inc. Main Business Overview
13.2.5 GE HealthCare Technologies Inc. Latest Developments
13.3 Sumitomo Heavy Industries, Ltd.
13.3.1 Sumitomo Heavy Industries, Ltd. Company Information
13.3.2 Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.3.3 Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sumitomo Heavy Industries, Ltd. Main Business Overview
13.3.5 Sumitomo Heavy Industries, Ltd. Latest Developments
13.4 Advanced Cyclotron Systems Inc.
13.4.1 Advanced Cyclotron Systems Inc. Company Information
13.4.2 Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.4.3 Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Advanced Cyclotron Systems Inc. Main Business Overview
13.4.5 Advanced Cyclotron Systems Inc. Latest Developments
13.5 Best Theratronics Ltd.
13.5.1 Best Theratronics Ltd. Company Information
13.5.2 Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.5.3 Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Best Theratronics Ltd. Main Business Overview
13.5.5 Best Theratronics Ltd. Latest Developments
13.6 PMB SAS
13.6.1 PMB SAS Company Information
13.6.2 PMB SAS Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.6.3 PMB SAS Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 PMB SAS Main Business Overview
13.6.5 PMB SAS Latest Developments
13.7 Sichuan Longevous Beamtech Co., Ltd.
13.7.1 Sichuan Longevous Beamtech Co., Ltd. Company Information
13.7.2 Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.7.3 Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Sichuan Longevous Beamtech Co., Ltd. Main Business Overview
13.7.5 Sichuan Longevous Beamtech Co., Ltd. Latest Developments
13.8 China Institute of Atomic Energy
13.8.1 China Institute of Atomic Energy Company Information
13.8.2 China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.8.3 China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 China Institute of Atomic Energy Main Business Overview
13.8.5 China Institute of Atomic Energy Latest Developments
13.9 ARTMS Inc.
13.9.1 ARTMS Inc. Company Information
13.9.2 ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.9.3 ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 ARTMS Inc. Main Business Overview
13.9.5 ARTMS Inc. Latest Developments
13.10 Comecer S.p.A.
13.10.1 Comecer S.p.A. Company Information
13.10.2 Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.10.3 Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Comecer S.p.A. Main Business Overview
13.10.5 Comecer S.p.A. Latest Developments
13.11 Tema Sinergie S.p.A.
13.11.1 Tema Sinergie S.p.A. Company Information
13.11.2 Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.11.3 Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Tema Sinergie S.p.A. Main Business Overview
13.11.5 Tema Sinergie S.p.A. Latest Developments
13.12 Von Gahlen International B.V.
13.12.1 Von Gahlen International B.V. Company Information
13.12.2 Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.12.3 Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Von Gahlen International B.V. Main Business Overview
13.12.5 Von Gahlen International B.V. Latest Developments
13.13 Trasis S.A.
13.13.1 Trasis S.A. Company Information
13.13.2 Trasis S.A. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.13.3 Trasis S.A. Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Trasis S.A. Main Business Overview
13.13.5 Trasis S.A. Latest Developments
13.14 Eckert & Ziegler Medical GmbH
13.14.1 Eckert & Ziegler Medical GmbH Company Information
13.14.2 Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.14.3 Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Eckert & Ziegler Medical GmbH Main Business Overview
13.14.5 Eckert & Ziegler Medical GmbH Latest Developments
13.15 Kinectrics Inc.
13.15.1 Kinectrics Inc. Company Information
13.15.2 Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.15.3 Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Kinectrics Inc. Main Business Overview
13.15.5 Kinectrics Inc. Latest Developments
13.16 Framatome
13.16.1 Framatome Company Information
13.16.2 Framatome Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.16.3 Framatome Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Framatome Main Business Overview
13.16.5 Framatome Latest Developments
13.17 NorthStar Medical Radioisotopes, LLC
13.17.1 NorthStar Medical Radioisotopes, LLC Company Information
13.17.2 NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
13.17.3 NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 NorthStar Medical Radioisotopes, LLC Main Business Overview
13.17.5 NorthStar Medical Radioisotopes, LLC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nuclear Medicine Radioisotope Production Systems Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Nuclear Medicine Radioisotope Production Systems Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cyclotron based Production Systems
Table 4. Major Players of Reactor Irradiation Production Systems
Table 5. Major Players of Generator and Separation Production Systems
Table 6. Major Players of Electron Accelerator and Neutron Source Production Systems
Table 7. Major Players of Others
Table 8. Global Nuclear Medicine Radioisotope Production Systems Sales by Production Route (2021-2026) & (Units)
Table 9. Global Nuclear Medicine Radioisotope Production Systems Sales Market Share by Production Route (2021-2026)
Table 10. Global Nuclear Medicine Radioisotope Production Systems Revenue by Production Route (2021-2026) & ($ million)
Table 11. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Production Route (2021-2026)
Table 12. Global Nuclear Medicine Radioisotope Production Systems Sale Price by Production Route (2021-2026) & (K US$/Unit)
Table 13. Major Players of Compact Low Energy Systems (≤20 MeV)
Table 14. Major Players of Medium Energy Multi Isotope Systems (20 to 35 MeV)
Table 15. Major Players of High Energy Isotope Production Systems (>35 MeV)
Table 16. Major Players of Others
Table 17. Global Nuclear Medicine Radioisotope Production Systems Sales by Energy Level (2021-2026) & (Units)
Table 18. Global Nuclear Medicine Radioisotope Production Systems Sales Market Share by Energy Level (2021-2026)
Table 19. Global Nuclear Medicine Radioisotope Production Systems Revenue by Energy Level (2021-2026) & ($ million)
Table 20. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Energy Level (2021-2026)
Table 21. Global Nuclear Medicine Radioisotope Production Systems Sale Price by Energy Level (2021-2026) & (K US$/Unit)
Table 22. Global Nuclear Medicine Radioisotope Production Systems Sale by Application (2021-2026) & (Units)
Table 23. Global Nuclear Medicine Radioisotope Production Systems Sale Market Share by Application (2021-2026)
Table 24. Global Nuclear Medicine Radioisotope Production Systems Revenue by Application (2021-2026) & ($ million)
Table 25. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Application (2021-2026)
Table 26. Global Nuclear Medicine Radioisotope Production Systems Sale Price by Application (2021-2026) & (K US$/Unit)
Table 27. Global Nuclear Medicine Radioisotope Production Systems Sales by Company (2021-2026) & (Units)
Table 28. Global Nuclear Medicine Radioisotope Production Systems Sales Market Share by Company (2021-2026)
Table 29. Global Nuclear Medicine Radioisotope Production Systems Revenue by Company (2021-2026) & ($ millions)
Table 30. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Company (2021-2026)
Table 31. Global Nuclear Medicine Radioisotope Production Systems Sale Price by Company (2021-2026) & (K US$/Unit)
Table 32. Key Manufacturers Nuclear Medicine Radioisotope Production Systems Producing Area Distribution and Sales Area
Table 33. Players Nuclear Medicine Radioisotope Production Systems Products Offered
Table 34. Nuclear Medicine Radioisotope Production Systems Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 35. New Products and Potential Entrants
Table 36. Market M&A Activity & Strategy
Table 37. Global Nuclear Medicine Radioisotope Production Systems Sales by Geographic Region (2021-2026) & (Units)
Table 38. Global Nuclear Medicine Radioisotope Production Systems Sales Market Share Geographic Region (2021-2026)
Table 39. Global Nuclear Medicine Radioisotope Production Systems Revenue by Geographic Region (2021-2026) & ($ millions)
Table 40. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Geographic Region (2021-2026)
Table 41. Global Nuclear Medicine Radioisotope Production Systems Sales by Country/Region (2021-2026) & (Units)
Table 42. Global Nuclear Medicine Radioisotope Production Systems Sales Market Share by Country/Region (2021-2026)
Table 43. Global Nuclear Medicine Radioisotope Production Systems Revenue by Country/Region (2021-2026) & ($ millions)
Table 44. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Country/Region (2021-2026)
Table 45. Americas Nuclear Medicine Radioisotope Production Systems Sales by Country (2021-2026) & (Units)
Table 46. Americas Nuclear Medicine Radioisotope Production Systems Sales Market Share by Country (2021-2026)
Table 47. Americas Nuclear Medicine Radioisotope Production Systems Revenue by Country (2021-2026) & ($ millions)
Table 48. Americas Nuclear Medicine Radioisotope Production Systems Sales by Production Route (2021-2026) & (Units)
Table 49. Americas Nuclear Medicine Radioisotope Production Systems Sales by Application (2021-2026) & (Units)
Table 50. APAC Nuclear Medicine Radioisotope Production Systems Sales by Region (2021-2026) & (Units)
Table 51. APAC Nuclear Medicine Radioisotope Production Systems Sales Market Share by Region (2021-2026)
Table 52. APAC Nuclear Medicine Radioisotope Production Systems Revenue by Region (2021-2026) & ($ millions)
Table 53. APAC Nuclear Medicine Radioisotope Production Systems Sales by Production Route (2021-2026) & (Units)
Table 54. APAC Nuclear Medicine Radioisotope Production Systems Sales by Application (2021-2026) & (Units)
Table 55. Europe Nuclear Medicine Radioisotope Production Systems Sales by Country (2021-2026) & (Units)
Table 56. Europe Nuclear Medicine Radioisotope Production Systems Revenue by Country (2021-2026) & ($ millions)
Table 57. Europe Nuclear Medicine Radioisotope Production Systems Sales by Production Route (2021-2026) & (Units)
Table 58. Europe Nuclear Medicine Radioisotope Production Systems Sales by Application (2021-2026) & (Units)
Table 59. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales by Country (2021-2026) & (Units)
Table 60. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Country (2021-2026)
Table 61. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales by Production Route (2021-2026) & (Units)
Table 62. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales by Application (2021-2026) & (Units)
Table 63. Key Market Drivers & Growth Opportunities of Nuclear Medicine Radioisotope Production Systems
Table 64. Key Market Challenges & Risks of Nuclear Medicine Radioisotope Production Systems
Table 65. Key Industry Trends of Nuclear Medicine Radioisotope Production Systems
Table 66. Nuclear Medicine Radioisotope Production Systems Raw Material
Table 67. Key Suppliers of Raw Materials
Table 68. Nuclear Medicine Radioisotope Production Systems Distributors List
Table 69. Nuclear Medicine Radioisotope Production Systems Customer List
Table 70. Global Nuclear Medicine Radioisotope Production Systems Sales Forecast by Region (2027-2032) & (Units)
Table 71. Global Nuclear Medicine Radioisotope Production Systems Revenue Forecast by Region (2027-2032) & ($ millions)
Table 72. Americas Nuclear Medicine Radioisotope Production Systems Sales Forecast by Country (2027-2032) & (Units)
Table 73. Americas Nuclear Medicine Radioisotope Production Systems Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 74. APAC Nuclear Medicine Radioisotope Production Systems Sales Forecast by Region (2027-2032) & (Units)
Table 75. APAC Nuclear Medicine Radioisotope Production Systems Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Europe Nuclear Medicine Radioisotope Production Systems Sales Forecast by Country (2027-2032) & (Units)
Table 77. Europe Nuclear Medicine Radioisotope Production Systems Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Forecast by Country (2027-2032) & (Units)
Table 79. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. Global Nuclear Medicine Radioisotope Production Systems Sales Forecast by Production Route (2027-2032) & (Units)
Table 81. Global Nuclear Medicine Radioisotope Production Systems Revenue Forecast by Production Route (2027-2032) & ($ millions)
Table 82. Global Nuclear Medicine Radioisotope Production Systems Sales Forecast by Application (2027-2032) & (Units)
Table 83. Global Nuclear Medicine Radioisotope Production Systems Revenue Forecast by Application (2027-2032) & ($ millions)
Table 84. Ion Beam Applications SA Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 85. Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 86. Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 87. Ion Beam Applications SA Main Business
Table 88. Ion Beam Applications SA Latest Developments
Table 89. GE HealthCare Technologies Inc. Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 90. GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 91. GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 92. GE HealthCare Technologies Inc. Main Business
Table 93. GE HealthCare Technologies Inc. Latest Developments
Table 94. Sumitomo Heavy Industries, Ltd. Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 95. Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 96. Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 97. Sumitomo Heavy Industries, Ltd. Main Business
Table 98. Sumitomo Heavy Industries, Ltd. Latest Developments
Table 99. Advanced Cyclotron Systems Inc. Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 100. Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 101. Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 102. Advanced Cyclotron Systems Inc. Main Business
Table 103. Advanced Cyclotron Systems Inc. Latest Developments
Table 104. Best Theratronics Ltd. Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 105. Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 106. Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 107. Best Theratronics Ltd. Main Business
Table 108. Best Theratronics Ltd. Latest Developments
Table 109. PMB SAS Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 110. PMB SAS Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 111. PMB SAS Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 112. PMB SAS Main Business
Table 113. PMB SAS Latest Developments
Table 114. Sichuan Longevous Beamtech Co., Ltd. Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 115. Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 116. Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 117. Sichuan Longevous Beamtech Co., Ltd. Main Business
Table 118. Sichuan Longevous Beamtech Co., Ltd. Latest Developments
Table 119. China Institute of Atomic Energy Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 120. China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 121. China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 122. China Institute of Atomic Energy Main Business
Table 123. China Institute of Atomic Energy Latest Developments
Table 124. ARTMS Inc. Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 125. ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 126. ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 127. ARTMS Inc. Main Business
Table 128. ARTMS Inc. Latest Developments
Table 129. Comecer S.p.A. Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 130. Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 131. Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 132. Comecer S.p.A. Main Business
Table 133. Comecer S.p.A. Latest Developments
Table 134. Tema Sinergie S.p.A. Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 135. Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 136. Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 137. Tema Sinergie S.p.A. Main Business
Table 138. Tema Sinergie S.p.A. Latest Developments
Table 139. Von Gahlen International B.V. Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 140. Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 141. Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 142. Von Gahlen International B.V. Main Business
Table 143. Von Gahlen International B.V. Latest Developments
Table 144. Trasis S.A. Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 145. Trasis S.A. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 146. Trasis S.A. Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 147. Trasis S.A. Main Business
Table 148. Trasis S.A. Latest Developments
Table 149. Eckert & Ziegler Medical GmbH Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 150. Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 151. Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 152. Eckert & Ziegler Medical GmbH Main Business
Table 153. Eckert & Ziegler Medical GmbH Latest Developments
Table 154. Kinectrics Inc. Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 155. Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 156. Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 157. Kinectrics Inc. Main Business
Table 158. Kinectrics Inc. Latest Developments
Table 159. Framatome Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 160. Framatome Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 161. Framatome Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 162. Framatome Main Business
Table 163. Framatome Latest Developments
Table 164. NorthStar Medical Radioisotopes, LLC Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 165. NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 166. NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 167. NorthStar Medical Radioisotopes, LLC Main Business
Table 168. NorthStar Medical Radioisotopes, LLC Latest Developments
Table 1. Nuclear Medicine Radioisotope Production Systems Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Nuclear Medicine Radioisotope Production Systems Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cyclotron based Production Systems
Table 4. Major Players of Reactor Irradiation Production Systems
Table 5. Major Players of Generator and Separation Production Systems
Table 6. Major Players of Electron Accelerator and Neutron Source Production Systems
Table 7. Major Players of Others
Table 8. Global Nuclear Medicine Radioisotope Production Systems Sales by Production Route (2021-2026) & (Units)
Table 9. Global Nuclear Medicine Radioisotope Production Systems Sales Market Share by Production Route (2021-2026)
Table 10. Global Nuclear Medicine Radioisotope Production Systems Revenue by Production Route (2021-2026) & ($ million)
Table 11. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Production Route (2021-2026)
Table 12. Global Nuclear Medicine Radioisotope Production Systems Sale Price by Production Route (2021-2026) & (K US$/Unit)
Table 13. Major Players of Compact Low Energy Systems (≤20 MeV)
Table 14. Major Players of Medium Energy Multi Isotope Systems (20 to 35 MeV)
Table 15. Major Players of High Energy Isotope Production Systems (>35 MeV)
Table 16. Major Players of Others
Table 17. Global Nuclear Medicine Radioisotope Production Systems Sales by Energy Level (2021-2026) & (Units)
Table 18. Global Nuclear Medicine Radioisotope Production Systems Sales Market Share by Energy Level (2021-2026)
Table 19. Global Nuclear Medicine Radioisotope Production Systems Revenue by Energy Level (2021-2026) & ($ million)
Table 20. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Energy Level (2021-2026)
Table 21. Global Nuclear Medicine Radioisotope Production Systems Sale Price by Energy Level (2021-2026) & (K US$/Unit)
Table 22. Global Nuclear Medicine Radioisotope Production Systems Sale by Application (2021-2026) & (Units)
Table 23. Global Nuclear Medicine Radioisotope Production Systems Sale Market Share by Application (2021-2026)
Table 24. Global Nuclear Medicine Radioisotope Production Systems Revenue by Application (2021-2026) & ($ million)
Table 25. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Application (2021-2026)
Table 26. Global Nuclear Medicine Radioisotope Production Systems Sale Price by Application (2021-2026) & (K US$/Unit)
Table 27. Global Nuclear Medicine Radioisotope Production Systems Sales by Company (2021-2026) & (Units)
Table 28. Global Nuclear Medicine Radioisotope Production Systems Sales Market Share by Company (2021-2026)
Table 29. Global Nuclear Medicine Radioisotope Production Systems Revenue by Company (2021-2026) & ($ millions)
Table 30. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Company (2021-2026)
Table 31. Global Nuclear Medicine Radioisotope Production Systems Sale Price by Company (2021-2026) & (K US$/Unit)
Table 32. Key Manufacturers Nuclear Medicine Radioisotope Production Systems Producing Area Distribution and Sales Area
Table 33. Players Nuclear Medicine Radioisotope Production Systems Products Offered
Table 34. Nuclear Medicine Radioisotope Production Systems Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 35. New Products and Potential Entrants
Table 36. Market M&A Activity & Strategy
Table 37. Global Nuclear Medicine Radioisotope Production Systems Sales by Geographic Region (2021-2026) & (Units)
Table 38. Global Nuclear Medicine Radioisotope Production Systems Sales Market Share Geographic Region (2021-2026)
Table 39. Global Nuclear Medicine Radioisotope Production Systems Revenue by Geographic Region (2021-2026) & ($ millions)
Table 40. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Geographic Region (2021-2026)
Table 41. Global Nuclear Medicine Radioisotope Production Systems Sales by Country/Region (2021-2026) & (Units)
Table 42. Global Nuclear Medicine Radioisotope Production Systems Sales Market Share by Country/Region (2021-2026)
Table 43. Global Nuclear Medicine Radioisotope Production Systems Revenue by Country/Region (2021-2026) & ($ millions)
Table 44. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Country/Region (2021-2026)
Table 45. Americas Nuclear Medicine Radioisotope Production Systems Sales by Country (2021-2026) & (Units)
Table 46. Americas Nuclear Medicine Radioisotope Production Systems Sales Market Share by Country (2021-2026)
Table 47. Americas Nuclear Medicine Radioisotope Production Systems Revenue by Country (2021-2026) & ($ millions)
Table 48. Americas Nuclear Medicine Radioisotope Production Systems Sales by Production Route (2021-2026) & (Units)
Table 49. Americas Nuclear Medicine Radioisotope Production Systems Sales by Application (2021-2026) & (Units)
Table 50. APAC Nuclear Medicine Radioisotope Production Systems Sales by Region (2021-2026) & (Units)
Table 51. APAC Nuclear Medicine Radioisotope Production Systems Sales Market Share by Region (2021-2026)
Table 52. APAC Nuclear Medicine Radioisotope Production Systems Revenue by Region (2021-2026) & ($ millions)
Table 53. APAC Nuclear Medicine Radioisotope Production Systems Sales by Production Route (2021-2026) & (Units)
Table 54. APAC Nuclear Medicine Radioisotope Production Systems Sales by Application (2021-2026) & (Units)
Table 55. Europe Nuclear Medicine Radioisotope Production Systems Sales by Country (2021-2026) & (Units)
Table 56. Europe Nuclear Medicine Radioisotope Production Systems Revenue by Country (2021-2026) & ($ millions)
Table 57. Europe Nuclear Medicine Radioisotope Production Systems Sales by Production Route (2021-2026) & (Units)
Table 58. Europe Nuclear Medicine Radioisotope Production Systems Sales by Application (2021-2026) & (Units)
Table 59. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales by Country (2021-2026) & (Units)
Table 60. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Country (2021-2026)
Table 61. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales by Production Route (2021-2026) & (Units)
Table 62. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales by Application (2021-2026) & (Units)
Table 63. Key Market Drivers & Growth Opportunities of Nuclear Medicine Radioisotope Production Systems
Table 64. Key Market Challenges & Risks of Nuclear Medicine Radioisotope Production Systems
Table 65. Key Industry Trends of Nuclear Medicine Radioisotope Production Systems
Table 66. Nuclear Medicine Radioisotope Production Systems Raw Material
Table 67. Key Suppliers of Raw Materials
Table 68. Nuclear Medicine Radioisotope Production Systems Distributors List
Table 69. Nuclear Medicine Radioisotope Production Systems Customer List
Table 70. Global Nuclear Medicine Radioisotope Production Systems Sales Forecast by Region (2027-2032) & (Units)
Table 71. Global Nuclear Medicine Radioisotope Production Systems Revenue Forecast by Region (2027-2032) & ($ millions)
Table 72. Americas Nuclear Medicine Radioisotope Production Systems Sales Forecast by Country (2027-2032) & (Units)
Table 73. Americas Nuclear Medicine Radioisotope Production Systems Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 74. APAC Nuclear Medicine Radioisotope Production Systems Sales Forecast by Region (2027-2032) & (Units)
Table 75. APAC Nuclear Medicine Radioisotope Production Systems Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Europe Nuclear Medicine Radioisotope Production Systems Sales Forecast by Country (2027-2032) & (Units)
Table 77. Europe Nuclear Medicine Radioisotope Production Systems Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Forecast by Country (2027-2032) & (Units)
Table 79. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. Global Nuclear Medicine Radioisotope Production Systems Sales Forecast by Production Route (2027-2032) & (Units)
Table 81. Global Nuclear Medicine Radioisotope Production Systems Revenue Forecast by Production Route (2027-2032) & ($ millions)
Table 82. Global Nuclear Medicine Radioisotope Production Systems Sales Forecast by Application (2027-2032) & (Units)
Table 83. Global Nuclear Medicine Radioisotope Production Systems Revenue Forecast by Application (2027-2032) & ($ millions)
Table 84. Ion Beam Applications SA Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 85. Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 86. Ion Beam Applications SA Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 87. Ion Beam Applications SA Main Business
Table 88. Ion Beam Applications SA Latest Developments
Table 89. GE HealthCare Technologies Inc. Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 90. GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 91. GE HealthCare Technologies Inc. Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 92. GE HealthCare Technologies Inc. Main Business
Table 93. GE HealthCare Technologies Inc. Latest Developments
Table 94. Sumitomo Heavy Industries, Ltd. Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 95. Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 96. Sumitomo Heavy Industries, Ltd. Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 97. Sumitomo Heavy Industries, Ltd. Main Business
Table 98. Sumitomo Heavy Industries, Ltd. Latest Developments
Table 99. Advanced Cyclotron Systems Inc. Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 100. Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 101. Advanced Cyclotron Systems Inc. Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 102. Advanced Cyclotron Systems Inc. Main Business
Table 103. Advanced Cyclotron Systems Inc. Latest Developments
Table 104. Best Theratronics Ltd. Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 105. Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 106. Best Theratronics Ltd. Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 107. Best Theratronics Ltd. Main Business
Table 108. Best Theratronics Ltd. Latest Developments
Table 109. PMB SAS Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 110. PMB SAS Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 111. PMB SAS Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 112. PMB SAS Main Business
Table 113. PMB SAS Latest Developments
Table 114. Sichuan Longevous Beamtech Co., Ltd. Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 115. Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 116. Sichuan Longevous Beamtech Co., Ltd. Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 117. Sichuan Longevous Beamtech Co., Ltd. Main Business
Table 118. Sichuan Longevous Beamtech Co., Ltd. Latest Developments
Table 119. China Institute of Atomic Energy Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 120. China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 121. China Institute of Atomic Energy Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 122. China Institute of Atomic Energy Main Business
Table 123. China Institute of Atomic Energy Latest Developments
Table 124. ARTMS Inc. Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 125. ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 126. ARTMS Inc. Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 127. ARTMS Inc. Main Business
Table 128. ARTMS Inc. Latest Developments
Table 129. Comecer S.p.A. Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 130. Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 131. Comecer S.p.A. Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 132. Comecer S.p.A. Main Business
Table 133. Comecer S.p.A. Latest Developments
Table 134. Tema Sinergie S.p.A. Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 135. Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 136. Tema Sinergie S.p.A. Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 137. Tema Sinergie S.p.A. Main Business
Table 138. Tema Sinergie S.p.A. Latest Developments
Table 139. Von Gahlen International B.V. Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 140. Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 141. Von Gahlen International B.V. Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 142. Von Gahlen International B.V. Main Business
Table 143. Von Gahlen International B.V. Latest Developments
Table 144. Trasis S.A. Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 145. Trasis S.A. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 146. Trasis S.A. Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 147. Trasis S.A. Main Business
Table 148. Trasis S.A. Latest Developments
Table 149. Eckert & Ziegler Medical GmbH Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 150. Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 151. Eckert & Ziegler Medical GmbH Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 152. Eckert & Ziegler Medical GmbH Main Business
Table 153. Eckert & Ziegler Medical GmbH Latest Developments
Table 154. Kinectrics Inc. Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 155. Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 156. Kinectrics Inc. Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 157. Kinectrics Inc. Main Business
Table 158. Kinectrics Inc. Latest Developments
Table 159. Framatome Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 160. Framatome Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 161. Framatome Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 162. Framatome Main Business
Table 163. Framatome Latest Developments
Table 164. NorthStar Medical Radioisotopes, LLC Basic Information, Nuclear Medicine Radioisotope Production Systems Manufacturing Base, Sales Area and Its Competitors
Table 165. NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Product Portfolios and Specifications
Table 166. NorthStar Medical Radioisotopes, LLC Nuclear Medicine Radioisotope Production Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 167. NorthStar Medical Radioisotopes, LLC Main Business
Table 168. NorthStar Medical Radioisotopes, LLC Latest Developments
LIST OF FIGURES
Figure 1. Picture of Nuclear Medicine Radioisotope Production Systems
Figure 2. Nuclear Medicine Radioisotope Production Systems Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nuclear Medicine Radioisotope Production Systems Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Nuclear Medicine Radioisotope Production Systems Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Nuclear Medicine Radioisotope Production Systems Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Nuclear Medicine Radioisotope Production Systems Sales Market Share by Country/Region (2025)
Figure 10. Nuclear Medicine Radioisotope Production Systems Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Cyclotron based Production Systems
Figure 12. Product Picture of Reactor Irradiation Production Systems
Figure 13. Product Picture of Generator and Separation Production Systems
Figure 14. Product Picture of Electron Accelerator and Neutron Source Production Systems
Figure 15. Product Picture of Others
Figure 16. Global Nuclear Medicine Radioisotope Production Systems Sales Market Share by Production Route in 2026
Figure 17. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Production Route (2021-2026)
Figure 18. Product Picture of Compact Low Energy Systems (≤20 MeV)
Figure 19. Product Picture of Medium Energy Multi Isotope Systems (20 to 35 MeV)
Figure 20. Product Picture of High Energy Isotope Production Systems (>35 MeV)
Figure 21. Product Picture of Others
Figure 22. Global Nuclear Medicine Radioisotope Production Systems Sales Market Share by Energy Level in 2026
Figure 23. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Energy Level (2021-2026)
Figure 24. Nuclear Medicine Radioisotope Production Systems Consumed in Hospital Nuclear Medicine Centers
Figure 25. Global Nuclear Medicine Radioisotope Production Systems Market: Hospital Nuclear Medicine Centers (2021-2026) & (Units)
Figure 26. Nuclear Medicine Radioisotope Production Systems Consumed in Commercial Radiopharmacies
Figure 27. Global Nuclear Medicine Radioisotope Production Systems Market: Commercial Radiopharmacies (2021-2026) & (Units)
Figure 28. Nuclear Medicine Radioisotope Production Systems Consumed in National Isotope Production Centers
Figure 29. Global Nuclear Medicine Radioisotope Production Systems Market: National Isotope Production Centers (2021-2026) & (Units)
Figure 30. Nuclear Medicine Radioisotope Production Systems Consumed in Research Institutes and Universities
Figure 31. Global Nuclear Medicine Radioisotope Production Systems Market: Research Institutes and Universities (2021-2026) & (Units)
Figure 32. Nuclear Medicine Radioisotope Production Systems Consumed in Nuclear Reactor Facilities
Figure 33. Global Nuclear Medicine Radioisotope Production Systems Market: Nuclear Reactor Facilities (2021-2026) & (Units)
Figure 34. Nuclear Medicine Radioisotope Production Systems Consumed in Radiopharmaceutical CDMO Sites
Figure 35. Global Nuclear Medicine Radioisotope Production Systems Market: Radiopharmaceutical CDMO Sites (2021-2026) & (Units)
Figure 36. Nuclear Medicine Radioisotope Production Systems Consumed in Others
Figure 37. Global Nuclear Medicine Radioisotope Production Systems Market: Others (2021-2026) & (Units)
Figure 38. Global Nuclear Medicine Radioisotope Production Systems Sale Market Share by Application (2025)
Figure 39. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Application in 2025
Figure 40. Nuclear Medicine Radioisotope Production Systems Sales by Company in 2025 (Units)
Figure 41. Global Nuclear Medicine Radioisotope Production Systems Sales Market Share by Company in 2025
Figure 42. Nuclear Medicine Radioisotope Production Systems Revenue by Company in 2025 ($ millions)
Figure 43. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Company in 2025
Figure 44. Global Nuclear Medicine Radioisotope Production Systems Sales Market Share by Geographic Region (2021-2026)
Figure 45. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Geographic Region in 2025
Figure 46. Americas Nuclear Medicine Radioisotope Production Systems Sales 2021-2026 (Units)
Figure 47. Americas Nuclear Medicine Radioisotope Production Systems Revenue 2021-2026 ($ millions)
Figure 48. APAC Nuclear Medicine Radioisotope Production Systems Sales 2021-2026 (Units)
Figure 49. APAC Nuclear Medicine Radioisotope Production Systems Revenue 2021-2026 ($ millions)
Figure 50. Europe Nuclear Medicine Radioisotope Production Systems Sales 2021-2026 (Units)
Figure 51. Europe Nuclear Medicine Radioisotope Production Systems Revenue 2021-2026 ($ millions)
Figure 52. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales 2021-2026 (Units)
Figure 53. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Revenue 2021-2026 ($ millions)
Figure 54. Americas Nuclear Medicine Radioisotope Production Systems Sales Market Share by Country in 2025
Figure 55. Americas Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Country (2021-2026)
Figure 56. Americas Nuclear Medicine Radioisotope Production Systems Sales Market Share by Production Route (2021-2026)
Figure 57. Americas Nuclear Medicine Radioisotope Production Systems Sales Market Share by Application (2021-2026)
Figure 58. United States Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 59. Canada Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 60. Mexico Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 61. Brazil Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 62. APAC Nuclear Medicine Radioisotope Production Systems Sales Market Share by Region in 2025
Figure 63. APAC Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Region (2021-2026)
Figure 64. APAC Nuclear Medicine Radioisotope Production Systems Sales Market Share by Production Route (2021-2026)
Figure 65. APAC Nuclear Medicine Radioisotope Production Systems Sales Market Share by Application (2021-2026)
Figure 66. China Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 67. Japan Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 68. South Korea Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 69. Southeast Asia Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 70. India Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 71. Australia Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 72. China Taiwan Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 73. Europe Nuclear Medicine Radioisotope Production Systems Sales Market Share by Country in 2025
Figure 74. Europe Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Country (2021-2026)
Figure 75. Europe Nuclear Medicine Radioisotope Production Systems Sales Market Share by Production Route (2021-2026)
Figure 76. Europe Nuclear Medicine Radioisotope Production Systems Sales Market Share by Application (2021-2026)
Figure 77. Germany Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 78. France Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 79. UK Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 80. Italy Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 81. Russia Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 82. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Market Share by Country (2021-2026)
Figure 83. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Market Share by Production Route (2021-2026)
Figure 84. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Market Share by Application (2021-2026)
Figure 85. Egypt Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 86. South Africa Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 87. Israel Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 88. Turkey Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 89. GCC Countries Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 90. Manufacturing Cost Structure Analysis of Nuclear Medicine Radioisotope Production Systems in 2026
Figure 91. Manufacturing Process Analysis of Nuclear Medicine Radioisotope Production Systems
Figure 92. Industry Chain Structure of Nuclear Medicine Radioisotope Production Systems
Figure 93. Channels of Distribution
Figure 94. Global Nuclear Medicine Radioisotope Production Systems Sales Market Forecast by Region (2027-2032)
Figure 95. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share Forecast by Region (2027-2032)
Figure 96. Global Nuclear Medicine Radioisotope Production Systems Sales Market Share Forecast by Production Route (2027-2032)
Figure 97. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share Forecast by Production Route (2027-2032)
Figure 98. Global Nuclear Medicine Radioisotope Production Systems Sales Market Share Forecast by Application (2027-2032)
Figure 99. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Nuclear Medicine Radioisotope Production Systems
Figure 2. Nuclear Medicine Radioisotope Production Systems Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nuclear Medicine Radioisotope Production Systems Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Nuclear Medicine Radioisotope Production Systems Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Nuclear Medicine Radioisotope Production Systems Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Nuclear Medicine Radioisotope Production Systems Sales Market Share by Country/Region (2025)
Figure 10. Nuclear Medicine Radioisotope Production Systems Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Cyclotron based Production Systems
Figure 12. Product Picture of Reactor Irradiation Production Systems
Figure 13. Product Picture of Generator and Separation Production Systems
Figure 14. Product Picture of Electron Accelerator and Neutron Source Production Systems
Figure 15. Product Picture of Others
Figure 16. Global Nuclear Medicine Radioisotope Production Systems Sales Market Share by Production Route in 2026
Figure 17. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Production Route (2021-2026)
Figure 18. Product Picture of Compact Low Energy Systems (≤20 MeV)
Figure 19. Product Picture of Medium Energy Multi Isotope Systems (20 to 35 MeV)
Figure 20. Product Picture of High Energy Isotope Production Systems (>35 MeV)
Figure 21. Product Picture of Others
Figure 22. Global Nuclear Medicine Radioisotope Production Systems Sales Market Share by Energy Level in 2026
Figure 23. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Energy Level (2021-2026)
Figure 24. Nuclear Medicine Radioisotope Production Systems Consumed in Hospital Nuclear Medicine Centers
Figure 25. Global Nuclear Medicine Radioisotope Production Systems Market: Hospital Nuclear Medicine Centers (2021-2026) & (Units)
Figure 26. Nuclear Medicine Radioisotope Production Systems Consumed in Commercial Radiopharmacies
Figure 27. Global Nuclear Medicine Radioisotope Production Systems Market: Commercial Radiopharmacies (2021-2026) & (Units)
Figure 28. Nuclear Medicine Radioisotope Production Systems Consumed in National Isotope Production Centers
Figure 29. Global Nuclear Medicine Radioisotope Production Systems Market: National Isotope Production Centers (2021-2026) & (Units)
Figure 30. Nuclear Medicine Radioisotope Production Systems Consumed in Research Institutes and Universities
Figure 31. Global Nuclear Medicine Radioisotope Production Systems Market: Research Institutes and Universities (2021-2026) & (Units)
Figure 32. Nuclear Medicine Radioisotope Production Systems Consumed in Nuclear Reactor Facilities
Figure 33. Global Nuclear Medicine Radioisotope Production Systems Market: Nuclear Reactor Facilities (2021-2026) & (Units)
Figure 34. Nuclear Medicine Radioisotope Production Systems Consumed in Radiopharmaceutical CDMO Sites
Figure 35. Global Nuclear Medicine Radioisotope Production Systems Market: Radiopharmaceutical CDMO Sites (2021-2026) & (Units)
Figure 36. Nuclear Medicine Radioisotope Production Systems Consumed in Others
Figure 37. Global Nuclear Medicine Radioisotope Production Systems Market: Others (2021-2026) & (Units)
Figure 38. Global Nuclear Medicine Radioisotope Production Systems Sale Market Share by Application (2025)
Figure 39. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Application in 2025
Figure 40. Nuclear Medicine Radioisotope Production Systems Sales by Company in 2025 (Units)
Figure 41. Global Nuclear Medicine Radioisotope Production Systems Sales Market Share by Company in 2025
Figure 42. Nuclear Medicine Radioisotope Production Systems Revenue by Company in 2025 ($ millions)
Figure 43. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Company in 2025
Figure 44. Global Nuclear Medicine Radioisotope Production Systems Sales Market Share by Geographic Region (2021-2026)
Figure 45. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Geographic Region in 2025
Figure 46. Americas Nuclear Medicine Radioisotope Production Systems Sales 2021-2026 (Units)
Figure 47. Americas Nuclear Medicine Radioisotope Production Systems Revenue 2021-2026 ($ millions)
Figure 48. APAC Nuclear Medicine Radioisotope Production Systems Sales 2021-2026 (Units)
Figure 49. APAC Nuclear Medicine Radioisotope Production Systems Revenue 2021-2026 ($ millions)
Figure 50. Europe Nuclear Medicine Radioisotope Production Systems Sales 2021-2026 (Units)
Figure 51. Europe Nuclear Medicine Radioisotope Production Systems Revenue 2021-2026 ($ millions)
Figure 52. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales 2021-2026 (Units)
Figure 53. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Revenue 2021-2026 ($ millions)
Figure 54. Americas Nuclear Medicine Radioisotope Production Systems Sales Market Share by Country in 2025
Figure 55. Americas Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Country (2021-2026)
Figure 56. Americas Nuclear Medicine Radioisotope Production Systems Sales Market Share by Production Route (2021-2026)
Figure 57. Americas Nuclear Medicine Radioisotope Production Systems Sales Market Share by Application (2021-2026)
Figure 58. United States Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 59. Canada Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 60. Mexico Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 61. Brazil Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 62. APAC Nuclear Medicine Radioisotope Production Systems Sales Market Share by Region in 2025
Figure 63. APAC Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Region (2021-2026)
Figure 64. APAC Nuclear Medicine Radioisotope Production Systems Sales Market Share by Production Route (2021-2026)
Figure 65. APAC Nuclear Medicine Radioisotope Production Systems Sales Market Share by Application (2021-2026)
Figure 66. China Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 67. Japan Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 68. South Korea Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 69. Southeast Asia Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 70. India Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 71. Australia Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 72. China Taiwan Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 73. Europe Nuclear Medicine Radioisotope Production Systems Sales Market Share by Country in 2025
Figure 74. Europe Nuclear Medicine Radioisotope Production Systems Revenue Market Share by Country (2021-2026)
Figure 75. Europe Nuclear Medicine Radioisotope Production Systems Sales Market Share by Production Route (2021-2026)
Figure 76. Europe Nuclear Medicine Radioisotope Production Systems Sales Market Share by Application (2021-2026)
Figure 77. Germany Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 78. France Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 79. UK Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 80. Italy Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 81. Russia Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 82. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Market Share by Country (2021-2026)
Figure 83. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Market Share by Production Route (2021-2026)
Figure 84. Middle East & Africa Nuclear Medicine Radioisotope Production Systems Sales Market Share by Application (2021-2026)
Figure 85. Egypt Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 86. South Africa Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 87. Israel Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 88. Turkey Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 89. GCC Countries Nuclear Medicine Radioisotope Production Systems Revenue Growth 2021-2026 ($ millions)
Figure 90. Manufacturing Cost Structure Analysis of Nuclear Medicine Radioisotope Production Systems in 2026
Figure 91. Manufacturing Process Analysis of Nuclear Medicine Radioisotope Production Systems
Figure 92. Industry Chain Structure of Nuclear Medicine Radioisotope Production Systems
Figure 93. Channels of Distribution
Figure 94. Global Nuclear Medicine Radioisotope Production Systems Sales Market Forecast by Region (2027-2032)
Figure 95. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share Forecast by Region (2027-2032)
Figure 96. Global Nuclear Medicine Radioisotope Production Systems Sales Market Share Forecast by Production Route (2027-2032)
Figure 97. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share Forecast by Production Route (2027-2032)
Figure 98. Global Nuclear Medicine Radioisotope Production Systems Sales Market Share Forecast by Application (2027-2032)
Figure 99. Global Nuclear Medicine Radioisotope Production Systems Revenue Market Share Forecast by Application (2027-2032)
